Author
Listed:
- Nika Maani
(Program for Genetics and Genome Biology, Hospital for Sick Children
University of Toronto, Medical Science Building)
- Nesrin Sabha
(Program for Genetics and Genome Biology, Hospital for Sick Children
University of Toronto, Medical Science Building
University of Toronto)
- Kamran Rezai
(Program for Genetics and Genome Biology, Hospital for Sick Children
University of Toronto, Medical Science Building)
- Arun Ramani
(Program for Genetics and Genome Biology, Hospital for Sick Children
University of Toronto
Centre for Computational Medicine, The Hospital for Sick Children)
- Linda Groom
(University of Rochester Medical Center School of Medicine and Dentistry)
- Nadine Eltayeb
(Program for Genetics and Genome Biology, Hospital for Sick Children)
- Faranak Mavandadnejad
(Program for Genetics and Genome Biology, Hospital for Sick Children)
- Andrea Pang
(Program for Genetics and Genome Biology, Hospital for Sick Children)
- Giulia Russo
(Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP))
- Michael Brudno
(Program for Genetics and Genome Biology, Hospital for Sick Children
University of Toronto
Centre for Computational Medicine, The Hospital for Sick Children)
- Volker Haucke
(Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP))
- Robert T. Dirksen
(University of Rochester Medical Center School of Medicine and Dentistry)
- James J. Dowling
(Program for Genetics and Genome Biology, Hospital for Sick Children
University of Toronto, Medical Science Building
University of Toronto)
Abstract
Myotubular myopathy (MTM) is a severe X-linked disease without existing therapies. Here, we show that tamoxifen ameliorates MTM-related histopathological and functional abnormalities in mice, and nearly doubles survival. The beneficial effects of tamoxifen are mediated primarily via estrogen receptor signaling, as demonstrated through in vitro studies and in vivo phenotypic rescue with estradiol. RNA sequencing and protein expression analyses revealed that rescue is mediated in part through post-transcriptional reduction of dynamin-2, a known MTM modifier. These findings demonstrate an unexpected ability of tamoxifen to improve the murine MTM phenotype, providing preclinical evidence to support clinical translation.
Suggested Citation
Nika Maani & Nesrin Sabha & Kamran Rezai & Arun Ramani & Linda Groom & Nadine Eltayeb & Faranak Mavandadnejad & Andrea Pang & Giulia Russo & Michael Brudno & Volker Haucke & Robert T. Dirksen & James , 2018.
"Tamoxifen therapy in a murine model of myotubular myopathy,"
Nature Communications, Nature, vol. 9(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07057-5
DOI: 10.1038/s41467-018-07057-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07057-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.